Development of Interactive Software for Bayesian Optimal Phase 1 Clinical Trial Design*
暂无分享,去创建一个
[1] F. Pukelsheim. Optimal Design of Experiments , 1993 .
[2] S Zacks,et al. Cancer phase I clinical trials: efficient dose escalation with overdose control. , 1998, Statistics in medicine.
[3] L. Haines,et al. Bayesian Optimal Designs for Phase I Clinical Trials , 2003, Biometrics.
[4] K. Chaloner,et al. The Equivalence of Constrained and Weighted Designs in Multiple Objective Design Problems , 1996 .
[5] Anthony C. Atkinson,et al. Optimum Experimental Designs , 1992 .
[6] J Whitehead,et al. Easy-to-implement Bayesian methods for dose-escalation studies in healthy volunteers. , 2001, Biostatistics.
[7] P. Laycock,et al. Optimum Experimental Designs , 1995 .
[8] M. Silvapulle. On the Existence of Maximum Likelihood Estimators for the Binomial Response Models , 1981 .
[9] J Whitehead,et al. Bayesian decision procedures for dose determining experiments. , 1995, Statistics in medicine.
[10] William F. Rosenberger,et al. Constrained Bayesian Optimal Designs for Phase I Clinical Trials: Continuous Dose Space , 2001 .
[11] William F Rosenberger,et al. Competing designs for phase I clinical trials: a review , 2002, Statistics in medicine.
[12] J Whitehead,et al. Bayesian decision procedures based on logistic regression models for dose-finding studies. , 1998, Journal of biopharmaceutical statistics.
[13] Peter E. Rossi,et al. Case Studies in Bayesian Statistics , 1998 .
[14] Nancy Flournoy,et al. A Clinical Experiment in Bone Marrow Transplantation: Estimating a Percentage Point of a Quantal Response Curve , 1993 .
[15] D. L. McLeish,et al. Sequential Designs in Bioassay , 1990 .